Skip to main content

Contract Management: DOD's Anthrax Vaccine Manufacturer Will Continue to Need Financial Assistance

T-NSIAD-00-140 Published: Apr 14, 2000. Publicly Released: Apr 14, 2000.
Jump To:

Highlights

Pursuant to a congressional request, GAO discussed the contractual relationship between the Department of Defense (DOD) and BioPort Corporation for production of the anthrax vaccine, focusing on: (1) the financial assistance DOD provided BioPort in 1999; and (2) additional financial assistance DOD is providing BioPort in 2000.

Full Report

Full Report (7 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Topics

Homeland Security
Advance paymentsBiological warfareChemical agentsBiological agentsAnthraxContract modificationsContract performanceContract termsDefense procurementDepartment of Defense contractorsFinancial analysisImmunization programsImmunization services